{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"A Phase 1, Open-Label, Dose Escalation and Expansion, Multicenter Study of Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells in Subjects with Unresectable, Locally Advanced, or Metastatic Gastric, Gastroesophageal Junction (GEJ), Esophageal, or Pancreatic Adenocarcinoma","item":"https:\/\/www.regionalcancercare.org\/trials\/a-phase-1-open-label-dose-escalation-and-expansion-multicenter-study-of-claudin-18-2-targeted-chimeric-antigen-receptor-t-cells-in-subjects-with-unresectable-locally-advanced-or-metastatic-gastri\/#breadcrumbitem"}]}